XML 19 R8.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
May 28, 2021
Nov. 27, 2020
May 29, 2020
May 28, 2021
May 29, 2020
May 29, 2020
Cash flows from operating activities:            
Net income (loss) $ (6,654) $ 2,027 $ 825 $ 1,217 $ (8,671)  
Adjustments to reconcile net income (loss) to net cash provided by operating activities:            
Depreciation and amortization       32,468 27,797  
Share-based compensation       24,867 15,510  
Provision for doubtful accounts receivable and sales returns       522 47  
Deferred income tax benefit       (3,083) 65  
Gain on disposal of property and equipment       (34) (19)  
Loss on mark-to-market adjustment of the capped call     2,924   7,719 $ 7,719
Loss on extinguishment of debt     192   6,822 6,822
Amortization of debt discounts and issuance costs       6,503 3,786  
Amortization of operating lease right-of-use assets       4,944 3,569  
Loss from mark-to-market adjustment of contingent consideration       16,400    
Changes in operating assets and liabilities:            
Accounts receivable       (15,455) (17,885)  
Inventories       (66,493) (72,481)  
Prepaid expenses and other assets       (14,163) (1,119)  
Accounts payable       116,166 95,687  
Operating lease liabilities       (4,460) (3,503)  
Other current and long-term liabilities       5,929 4,903  
Net cash provided by operating activities       105,328 62,227  
Cash flows from investing activities:            
Capital expenditures and deposits on equipment       (40,017) (16,889)  
Proceeds from sale of property and equipment       222 154  
Acquisition of business, net of cash acquired       (28,613)    
Net cash used in investing activities       (68,408) (16,735)  
Cash flows from financing activities:            
Repurchase of ordinary shares       (44,330)    
Proceeds from FINEP loan       11,439    
Proceeds from borrowings under revolving line of credit       114,500 60,500  
Repayments of borrowings under revolving line of credit       (89,500) (60,500)  
Proceeds from issuance of ordinary shares from share option exercises       9,542 1,941  
Proceeds from issuance of ordinary shares from ESPP       3,615 2,984  
Tax payments due upon issuance of ordinary shares for release of RSUs       (3,971) (653)  
Purchase of capped call         (21,825)  
Proceeds from convertible notes due 2026, net of discount         243,125  
Payment for extinguishment of long-term debt         (204,904)  
Net cash provided by financing activities       1,295 12,751  
Effect of exchange rate changes on cash and cash equivalents       (34) (24,537)  
Net increase in cash and cash equivalents       38,181 33,706  
Cash and cash equivalents at beginning of period   $ 150,811   150,811 98,139  
Cash and cash equivalents at end of period $ 188,992   $ 131,845 188,992 131,845 $ 131,845
Cash paid during the period:            
Cash paid for interest       3,398 9,939  
Cash paid for income taxes, net of refunds       5,405 6,146  
Noncash activities information:            
Fair value of non-cash consideration for acquisition of business (see Note 2)       160,723    
Capital expenditures included in accounts payable at period end       $ 2,355 3,720  
Unpaid debt fees related to convertible notes due 2026         1,990  
Term Loan            
Cash flows from financing activities:            
Long-term debt payments         (5,625)  
BNDES            
Cash flows from financing activities:            
Long-term debt payments         $ (2,292)